AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. (Nasdaq:MIRN), a clinical-stage biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics, today announced that the Company will host a conference call and live webcast on Tuesday, March 29, 2016 at 5:00 p.m. ET to report its fourth quarter and full year 2015 financial results and provide a clinical program and business update.
